SCHEMBL30269662

SCHEMBL30269662

COCCNc1cc(Br)ncc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.44
▸ MAPT P10636 1/20 0.44
▸ PTGER4 P35408 3/20 0.43
▸ NCF1 P14598 2/20 0.43
▸ LMNA P02545 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HCAR3 P49019 2/20 0.35
▸ UTS2R Q9UKP6 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ P2RX3 P56373 1/20 0.35
▸ P2RX2 Q9UBL9 1/20 0.35
▸ PDPK1 O15530 1/20 0.34
▸ LDHA P00338 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ APEX1 P27695 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CASP7 P55210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23235738 1.00 ALDH1A1 (0.44) ALDH1A1MAPTPTGER4NCF1LMNA
SCHEMBL29492781 0.81 ALDH1A1 (0.44) ALDH1A1MAPTPTGER4NCF1LMNA
SCHEMBL24270763 0.81 ALDH1A1 (0.44) ALDH1A1MAPTPTGER4NCF1LMNA
SCHEMBL30676115 0.76 LMNA (0.65) ALDH1A1MAPTPTGER4LMNASMN1; SMN2
SCHEMBL23235710 0.76 LMNA (0.65) ALDH1A1MAPTPTGER4LMNASMN1; SMN2
SCHEMBL20266451 0.75 NCF1 (0.43) ALDH1A1MAPTPTGER4NCF1LMNA
SCHEMBL15774438 0.74 PTGER4 (0.60) ALDH1A1MAPTPTGER4NCF1LMNA
SCHEMBL1519220 0.74 PTGER4 (0.49) ALDH1A1MAPTPTGER4NCF1LMNA
SCHEMBL1584807 0.72 UHRF1 (0.39) HTT
SCHEMBL30711414 0.72 UHRF1 (0.39) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270196-A1 GLP-1 Receptor Agonists and Uses Thereof PFIZER INC. (US) 2025-08-28 — — US disclosed
US-12331041-B2 GLP-1 receptor agonists and uses thereof PFIZER INC. (US) 2025-06-17 — — US disclosed
US-20240132483-A1 GLP-1 Receptor Agonists and Uses Thereof PFIZER INC. (US) 2024-04-25 — — US disclosed
US-11858916-B2 GLP-1 receptor agonists and uses thereof PFIZER INC. (US) 2024-01-02 — — US disclosed
CN-112566637-B GLP-1 receptor agonists and uses thereof 辉瑞公司 2023-11-14 — — CN disclosed
EP-3806855-B1 GLP-1 RECEPTOR AGONISTS AND USES THEREOF PFIZER (US) 2023-03-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12331041-B2 GLP-1 receptor agonists and uses thereof GLP1R, GIPR, GCGR ALDH1A1 907/4885MAPT 4832/4885PTGER4 1553/4885
US-11858916-B2 GLP-1 receptor agonists and uses thereof GLP1R, GIPR, GCGR ALDH1A1 907/4885MAPT 4832/4885PTGER4 1553/4885
US-20240132483-A1 GLP-1 Receptor Agonists and Uses Thereof GLP1R, GIPR, GCGR ALDH1A1 907/4885MAPT 4832/4885PTGER4 1553/4885
US-20250270196-A1 GLP-1 Receptor Agonists and Uses Thereof GLP1R, GIPR, GCGR ALDH1A1 907/4885MAPT 4832/4885PTGER4 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback